- Lobbying
- astellas AND pharma AND us
Lobbying Arrangements Results for 'Astellas Pharma Us'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Regulation of drugs |
Astellas Pharma US Inc.
|
POLICY NAVIGATION GROUP | |||
Details Issues related to antibiotic development incentives and drug shortage legislation. |
Astellas Pharma US, Inc.
Pharmaceutical manufacturing and marketing. |
ARNOLD & PORTER LLP | |||
Details H.R.4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Accountability Act of 2014, provisions related to prescription drug services. |
Astellas Pharma US, Inc.
Pharmaceuticals |
ML STRATEGIES, LLC | |||
Details General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation. |
Astellas Pharma US, Inc.
|
East End Group, LLC. | |||
Details Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplanation; Patient Protection and Affordable Care Act (P.L. 111-148); Prescription Drug... |
Astellas Pharma US
Pharmaceutical company |
CAPITOL HILL CONSULTING GROUP | |||
Details Reimbursement Issues |
Astellas Pharma US
Pharmaceutical Manufacturer |
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs, International Reference Pricing, Oncology Screening Awareness; HR 5376 Build Back Better Act/Inflation... |
Astellas Pharma US, Inc.
|
in-house lobbying | |||
Details Consolidated Appropriations Act, 2023, FDA provisions; Issues related to P.L. 96-517, the Bayh-Dole Act; general issues related to drug research and innovation. |
Astellas Pharma US, Inc.
|
PORTERFIELD, FETTIG & SEARS, LLC | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Astellas Pharma US, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details issues related to pharmaceutical drugs |
ASTELLAS PHARMA US
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Monitoring issues related to the FDA user fee reauthorization bill. Monitor issues related to the negotiations of prescription drugs in Medicare. Issues related to Bayh-Dole Act (Pub.L. 96-517). |
Astellas Pharma US, Inc.
|
NVG, LLC | |||
Details Transparency Policy Issues, Medicare Part D, International Reference Pricing, Oncology Screening Awareness, Value-based Payment Arrangements for Gene Therapy (no specific bills); H.R. 2666 MVP Act,... |
Astellas Gene Therapies, Inc. a Delaware Corporation
|
in-house lobbying | |||
Details H.R. 6743, Were Addressing the Realities of Menopause (WARM) Act of 2023 H.Res. 806, Expressing support for the recognition of October 2023, as "World Menopause Awareness Month" and expressing the ... |
Astellas Pharma US, Inc
|
theGROUP DC, LLC | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to IP pro... |
Astellas Pharma US, Inc.
|
Tiber Creek Group | |||
Details Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Women's health issues; WARM Act (H.R. 6743) Issues related to Medicare Part D, including reforms, non-interference, rebate... |
Astellas Pharma US, Inc.
|
Roberti Global (fka Roberti White, LLC) | |||
Details Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 11... |
Astellas Pharma US, Inc.
|
Capitol Counsel, LLC | |||
Details women's health, cancer |
Astellas Pharma US, Inc
Pharmaceutical company |
Tarplin, Downs & Young, LLC |